Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Bifunctional properties and characterization of a novel sialidase with esterase activity from Bifidobacterium bifidum.

Ashida H, Tanigawa K, Kiyohara M, Katoh T, Katayama T, Yamamoto K.

Biosci Biotechnol Biochem. 2018 Jul 20:1-10. doi: 10.1080/09168451.2018.1497944. [Epub ahead of print]

PMID:
30027820
2.

Assessing the Degree of Compassion Satisfaction and Compassion Fatigue Among Critical Care, Oncology, and Charge Nurses.

Al-Majid S, Carlson N, Kiyohara M, Faith M, Rakovski C.

J Nurs Adm. 2018 Jun;48(6):310-315. doi: 10.1097/NNA.0000000000000620.

PMID:
29794595
3.

The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients.

Ito T, Fujimoto N, Ishikawa E, Dohi K, Fujimoto M, Murata T, Kiyohara M, Takeuchi H, Koyabu S, Nishimura H, Takeuchi T, Ito M.

Clin Exp Hypertens. 2018 Mar 27:1-8. doi: 10.1080/10641963.2018.1445753. [Epub ahead of print]

PMID:
29584458
4.

Discovery of GnIH and Its Role in Hypothyroidism-Induced Delayed Puberty.

Tsutsui K, Son YL, Kiyohara M, Miyata I.

Endocrinology. 2018 Jan 1;159(1):62-68. doi: 10.1210/en.2017-00300. Review.

PMID:
28938445
5.

EMP2 is a novel therapeutic target for endometrial cancer stem cells.

Kiyohara MH, Dillard C, Tsui J, Kim SR, Lu J, Sachdev D, Goodglick L, Tong M, Torous VF, Aryasomayajula C, Wang W, Najafzadeh P, Gordon LK, Braun J, McDermott S, Wicha MS, Wadehra M.

Oncogene. 2017 Oct 19;36(42):5793-5807. doi: 10.1038/onc.2017.142. Epub 2017 Jun 12.

6.

Involvement of gonadotropin-inhibitory hormone in pubertal disorders induced by thyroid status.

Kiyohara M, Son YL, Tsutsui K.

Sci Rep. 2017 Apr 21;7(1):1042. doi: 10.1038/s41598-017-01183-8.

7.

In-situ and real-time growth observation of high-quality protein crystals under quasi-microgravity on earth.

Nakamura A, Ohtsuka J, Kashiwagi T, Numoto N, Hirota N, Ode T, Okada H, Nagata K, Kiyohara M, Suzuki E, Kita A, Wada H, Tanokura M.

Sci Rep. 2016 Feb 26;6:22127. doi: 10.1038/srep22127.

8.

Tracing microbiota changes in yamahai-moto, the traditional Japanese sake starter.

Koyanagi T, Nakagawa A, Kiyohara M, Matsui H, Tsuji A, Barla F, Take H, Katsuyama Y, Tokuda K, Nakamura S, Minami H, Enomoto T, Katayama T, Kumagai H.

Biosci Biotechnol Biochem. 2016;80(2):399-406. doi: 10.1080/09168451.2015.1095067. Epub 2015 Oct 19.

PMID:
26479869
9.

Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.

Qin Y, Fu M, Takahashi M, Iwanami A, Kuga D, Rao RG, Sudhakar D, Huang T, Kiyohara M, Torres K, Dillard C, Inagaki A, Kasahara N, Goodglick L, Braun J, Mischel PS, Gordon LK, Wadehra M.

J Biol Chem. 2014 May 16;289(20):13974-85. doi: 10.1074/jbc.M113.543728. Epub 2014 Mar 18.

10.

Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.

Fu M, Maresh EL, Helguera GF, Kiyohara M, Qin Y, Ashki N, Daniels-Wells TR, Aziz N, Gordon LK, Braun J, Elshimali Y, Soslow RA, Penichet ML, Goodglick L, Wadehra M.

Mol Cancer Ther. 2014 Apr;13(4):902-15. doi: 10.1158/1535-7163.MCT-13-0199. Epub 2014 Jan 21.

11.

Peroxynitrite upregulates angiogenic factors VEGF-A, BFGF, and HIF-1α in human corneal limbal epithelial cells.

Ashki N, Chan AM, Qin Y, Wang W, Kiyohara M, Lin L, Braun J, Wadehra M, Gordon LK.

Invest Ophthalmol Vis Sci. 2014 Mar 19;55(3):1637-46. doi: 10.1167/iovs.13-12410.

12.

Should we measure fetal omphalocele diameter for prediction of perinatal outcome?

Kiyohara MY, Brizot ML, Liao AW, Francisco RP, Tannuri AC, Krebs VL, Zugaib M.

Fetal Diagn Ther. 2014;35(1):44-50. doi: 10.1159/000355936. Epub 2013 Nov 29.

PMID:
24296426
13.

Pyrosequencing analysis of microbiota in Kaburazushi, a traditional medieval sushi in Japan.

Koyanagi T, Nakagawa A, Kiyohara M, Matsui H, Yamamoto K, Barla F, Take H, Katsuyama Y, Tsuji A, Shijimaya M, Nakamura S, Minami H, Enomoto T, Katayama T, Kumagai H.

Biosci Biotechnol Biochem. 2013;77(10):2125-30. Epub 2013 Oct 7.

14.

Lacto-N-biosidase encoded by a novel gene of Bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression.

Sakurama H, Kiyohara M, Wada J, Honda Y, Yamaguchi M, Fukiya S, Yokota A, Ashida H, Kumagai H, Kitaoka M, Yamamoto K, Katayama T.

J Biol Chem. 2013 Aug 30;288(35):25194-206. doi: 10.1074/jbc.M113.484733. Epub 2013 Jul 10.

15.

EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.

Gordon LK, Kiyohara M, Fu M, Braun J, Dhawan P, Chan A, Goodglick L, Wadehra M.

Oncogene. 2013 Nov 14;32(46):5369-76. doi: 10.1038/onc.2012.622. Epub 2013 Jan 21.

16.

Bifidobacterial α-galactosidase with unique carbohydrate-binding module specifically acts on blood group B antigen.

Wakinaka T, Kiyohara M, Kurihara S, Hirata A, Chaiwangsri T, Ohnuma T, Fukamizo T, Katayama T, Ashida H, Yamamoto K.

Glycobiology. 2013 Feb;23(2):232-40. doi: 10.1093/glycob/cws142. Epub 2012 Oct 22.

PMID:
23089618
17.

Changes in microbiota population during fermentation of narezushi as revealed by pyrosequencing analysis.

Kiyohara M, Koyanagi T, Matsui H, Yamamoto K, Take H, Katsuyama Y, Tsuji A, Miyamae H, Kondo T, Nakamura S, Katayama T, Kumagai H.

Biosci Biotechnol Biochem. 2012;76(1):48-52. Epub 2012 Jan 7.

18.

α-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway.

Kiyohara M, Nakatomi T, Kurihara S, Fushinobu S, Suzuki H, Tanaka T, Shoda S, Kitaoka M, Katayama T, Yamamoto K, Ashida H.

J Biol Chem. 2012 Jan 2;287(1):693-700. doi: 10.1074/jbc.M111.277384. Epub 2011 Nov 16.

19.

Pyrosequencing survey of the microbial diversity of 'narezushi', an archetype of modern Japanese sushi.

Koyanagi T, Kiyohara M, Matsui H, Yamamoto K, Kondo T, Katayama T, Kumagai H.

Lett Appl Microbiol. 2011 Dec;53(6):635-40. doi: 10.1111/j.1472-765X.2011.03155.x. Epub 2011 Oct 19.

20.

Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides.

Yoshida E, Sakurama H, Kiyohara M, Nakajima M, Kitaoka M, Ashida H, Hirose J, Katayama T, Yamamoto K, Kumagai H.

Glycobiology. 2012 Mar;22(3):361-8. doi: 10.1093/glycob/cwr116. Epub 2011 Sep 16.

PMID:
21926104
21.

An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates.

Kiyohara M, Tanigawa K, Chaiwangsri T, Katayama T, Ashida H, Yamamoto K.

Glycobiology. 2011 Apr;21(4):437-47. doi: 10.1093/glycob/cwq175. Epub 2010 Oct 29.

PMID:
21036948
22.

Cooperation of β-galactosidase and β-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure.

Miwa M, Horimoto T, Kiyohara M, Katayama T, Kitaoka M, Ashida H, Yamamoto K.

Glycobiology. 2010 Nov;20(11):1402-9. doi: 10.1093/glycob/cwq101. Epub 2010 Jun 24.

PMID:
20581010
23.

Pancreatic cancer therapy with a novel pump for controlled drug release.

Haramoto M, Kohno M, Nakajima O, Horibe T, Kiyohara M, Fukazawa H, Togawa T, Kawakami K.

Oncol Rep. 2010 Feb;23(2):365-70.

PMID:
20043096
24.

Characterization and application of carbohydrate-binding modules of beta-1,3-xylanase XYL4.

Kiyohara M, Sakaguchi K, Yamaguchi K, Araki T, Ito M.

J Biochem. 2009 Nov;146(5):633-41. doi: 10.1093/jb/mvp108. Epub 2009 Jul 15.

PMID:
19605459
25.

Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates.

Ashida H, Miyake A, Kiyohara M, Wada J, Yoshida E, Kumagai H, Katayama T, Yamamoto K.

Glycobiology. 2009 Sep;19(9):1010-7. doi: 10.1093/glycob/cwp082. Epub 2009 Jun 11.

PMID:
19520709
26.

Prebiotic effect of lacto-N-biose I on bifidobacterial growth.

Kiyohara M, Tachizawa A, Nishimoto M, Kitaoka M, Ashida H, Yamamoto K.

Biosci Biotechnol Biochem. 2009 May;73(5):1175-9. Epub 2009 May 7.

27.

Characterization of two different endo-alpha-N-acetylgalactosaminidases from probiotic and pathogenic enterobacteria, Bifidobacterium longum and Clostridium perfringens.

Ashida H, Maki R, Ozawa H, Tani Y, Kiyohara M, Fujita M, Imamura A, Ishida H, Kiso M, Yamamoto K.

Glycobiology. 2008 Sep;18(9):727-34. doi: 10.1093/glycob/cwn053. Epub 2008 Jun 17.

PMID:
18559962
28.

Irradiation prolongs survival of Alport mice.

Katayama K, Kawano M, Naito I, Ishikawa H, Sado Y, Asakawa N, Murata T, Oosugi K, Kiyohara M, Ishikawa E, Ito M, Nomura S.

J Am Soc Nephrol. 2008 Sep;19(9):1692-700. doi: 10.1681/ASN.2007070829. Epub 2008 May 14.

29.

Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure.

Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M, Kumagai H, Katayama T, Yamamoto K.

Appl Environ Microbiol. 2008 Jul;74(13):3996-4004. doi: 10.1128/AEM.00149-08. Epub 2008 May 9. Erratum in: Appl Environ Microbiol. 2009 Oct;75(19):6414.

31.

A novel endoglycoceramidase hydrolyzes oligogalactosylceramides to produce galactooligosaccharides and ceramides.

Ishibashi Y, Nakasone T, Kiyohara M, Horibata Y, Sakaguchi K, Hijikata A, Ichinose S, Omori A, Yasui Y, Imamura A, Ishida H, Kiso M, Okino N, Ito M.

J Biol Chem. 2007 Apr 13;282(15):11386-96. Epub 2007 Jan 23.

32.
33.
34.

Preparation and preliminary X-ray analysis of the catalytic module of beta-1,3-xylanase from the marine bacterium Vibrio sp. AX-4.

Sakaguchi K, Kiyohara M, Watanabe N, Yamaguchi K, Ito M, Kawamura T, Tanaka I.

Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1470-2. Epub 2004 Jul 21.

PMID:
15272180
35.

[The world of the patients: an expectation on nursing].

Kiyohara M.

Kangogaku Zasshi. 1978 Jun;42(6):612-9. Japanese. No abstract available.

PMID:
418251
36.

[Relationship between pain sensation and blood coagulation-fibrinolysis].

Abe T, Kiyohara M, Ikemori R.

Arerugi. 1970 Aug;19(8):634-7. Japanese. No abstract available.

PMID:
5458424
37.

[Physiology of pain].

Kiyohara M.

Nihon Ishikai Zasshi. 1969 Jun 1;61(11):1287-93. Japanese. No abstract available.

PMID:
5817736
38.

[Treatment of pain in malignant tumors in the terminal stage].

Kiyohara M.

Naika. 1968 Sep;22(3):702-6. Japanese. No abstract available.

PMID:
4179202
39.

[Pain].

Kiyohara M.

Kangogaku Zasshi. 1968 Apr;32(4):38-41. Japanese. No abstract available.

PMID:
4969041
40.

[Non-narcotic analgesics].

Kiyohara M.

Naika. 1967 Jun;19(6):1281-9. Japanese. No abstract available.

PMID:
6079612
41.

[Recent problems in pain].

Yamamura H, Kiyohara M.

Shinkei Kenkyu No Shimpo. 1967 Mar;11(1):3-9. Review. Japanese. No abstract available.

PMID:
4861804
42.

[Measurement of pain].

Kiyohara M.

Shinkei Kenkyu No Shimpo. 1967 Mar;11(1):10-23. Review. Japanese. No abstract available.

PMID:
4861800
43.

[Subarachnoid phenol block in the treatment of refractory pain in the terminal stage of malignant abdominal tumors].

Morikawa K, Fujiwara T, Kiyohara M.

Masui. 1966 Jun;15(6):489-96. Japanese. No abstract available.

PMID:
4164698
44.

[Recent trends at the Pain Clinic of the University of Tokyo Hospital].

Kiyohara M.

Masui. 1965 Oct;14(10):959-66. Japanese. No abstract available.

PMID:
5893232

Supplemental Content

Loading ...
Support Center